Search for: "ANDREW BULL"
Results 1 - 20
of 465
Sorted by Relevance
|
Sort by Date
15 Aug 2014, 9:16 pm
• Ethics • USPTO Perspective -- to be presented by Andrew Byrnes, Chief of Staff, U.S. [read post]
11 May 2007, 2:07 am
Killing cows and bulls violates Hindu religious principles. [read post]
23 Feb 2011, 5:00 am
The webinar will cover: • How can I transform my idea into a brand? [read post]
18 Apr 2014, 8:44 pm
The conference will consist of the following sessions: • What IP Lawyers Should Know About ARDC Proceedings and Client Complaints • Movie Lawyer Ethics: Hollywood's Lessons for IP Lawyers • Spoliation Issues in IP Cases • Ethical Issues in Biotechnology Patent Law -- to be presented by Patent Docs contributor Andrew Williams of McDonnell Boehnen Hulbert & Berghoff LLP • Conflicts and Waivers in Patent Law... [read post]
13 Jun 2017, 3:18 pm
He was previously employed at: • Bank of America (December 2009 – October 2011) Continue Reading [read post]
31 Oct 2021, 9:25 pm
• An update on... [read post]
18 Jan 2020, 9:35 pm
Schlitter and Andrew C. [read post]
10 Apr 2021, 8:20 pm
• Writing robust claims around specific antibody drug candidates • Inventive step when the target is known • What data... [read post]
25 Jun 2016, 8:28 pm
Andrew M. [read post]
4 Sep 2022, 8:45 pm
The webinar will address the following topics: • Where to enter the national/regional phase • When to enter the national/regional phase (for example we will explore strategies involving staggering national/regional phase entry) • What claims to include • Prosecution strategies,... [read post]
10 Mar 2009, 4:00 am
In his budget proposal, President Obama is reviving the idea of taxing carried interest as regular income, Andrew Ross Sorkin notes in his latest DealBook column. [read post]
7 Apr 2011, 9:21 am
Andrew Shirvell: Complaint [PDF] [read post]
10 Mar 2018, 9:15 pm
The agenda for the meeting is as follows: • Welcoming and Opening Remarks (10:00 - 10:10 am EDT) -- Daniel Sullivan and Andrew Wang, Directors, TC1600, USPTO • Obviousness of Biologics: Identifying the Biggest Challenges (10:10 - 11:00 am) -- Carla Mouta-Bellum of Arrigo, Lee, Guttman & Mouta-Bellum LLP • 103 KSR Rationales (11:00 - 11:50 am) -- Lora Driscoll, QAS, TC1600, USPTO • Lunch (11:50 am - 12:50 pm) •… [read post]
4 Nov 2017, 9:11 pm
The agenda for the meeting is as follows: • Welcoming and Opening Remarks (10:00 - 10:10 am EDT) -- Daniel Sullivan, Wanda Walker, and Andrew Wang, Directors, TC1600, USPTO • Application Readiness (10:10 - 14:40 am) -- Martin Rater, Senior Statistician USPTO • 112(b)- Practitioners' Perspective (10:40 - 11:40 am) -- Melissa Brand, IP Policy Director, BIO; Rachel Elsby of Akin Gump • Lunch (11:40 am - 12:10 pm) •… [read post]
25 Sep 2016, 8:06 pm
According to the FDA's press release, Amjevita is approved for the following indications in adult patients: • moderately to severely active rheumatoid arthritis; • active psoriatic arthritis; • active ankylosing spondylitis (an arthritis that... [read post]
25 Feb 2017, 8:51 pm
In this presentation, MBHB attorney and Patent Docs author Andrew Williams, Ph.D. and MBHB attorney James L. [read post]
29 Jul 2017, 8:21 pm
The webinar will cover the following topics: • Understanding how the CREATE Act led the way for evolution to the AIA • Overcoming Prior Art Based on Joint Inventorship [35 USC 102(b) exceptions] • Overcoming Prior Art... [read post]
14 Feb 2014, 8:47 pm
Andrew Williams of McDonnell Boehnen Hulbert & Berghoff, LLP • Gene Patenting Panel -- including Patent Docs author Dr. [read post]
5 May 2019, 9:55 pm
The agenda for the meeting is as follows: • Welcoming and Opening Remarks (9:00 - 9:20 am EDT) -- Damian Porcari, Director, Midwest Regional Office, and Andrew Wang, Gary Jones, and Daniel Sullivan, Directors, TC1600, USPTO • TC quality action plan (9:20 - 9:50 am) -- Anne Gussow, QAS, TC1600, USPTO • Antibody decisions and the written description requirement (9:50 - 10:30 am) -- Lora... [read post]
8 Aug 2015, 9:00 pm
Andrew W. [read post]
